Potential implications of the new pharmacotherapies on obesity management The mean WL in clinical trials with the most efficacious new obesity pharmacotherapies ranges between 15% and 25% at 1 year (and it may be even higher for some agents that have not reached weight plateau at study completion)
(2023, September 22)
TAC surgery was associated with the upregulation of the hypertrophic cardiomyocyte biomarkers atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and -myosin heavy chain (-MHC), whereas these levels were significantly decreased in cardiac tissue samples from PQQ-treated mice that underwent TAC surgery (Figure 1J)
Increased inflammation leads to worsening renal function, which, in turn, causes higher triglyceride levels, lower HDL-C, and variable amounts of oxidized LDL-C
Microsomal triglyceride transfer protein (MTTP), an abundant protein in ADSC-Exos, mitigates lipid ROS accumulation through the PRAP1/ZEB1/GPX4 signaling pathway
